Analysis of global biochips industry, 2012 2018 broucher

ANALYSIS OF GLOBAL BIOCHIPS INDUSTRY, 2012-2018 GLOBAL TRENDS, ESTIMATES AND FORECASTS

PRICE: US$4450 NO. OF PAGES: 483

TABLES/CHARTS: 182 REPORT CODE: ARMMR114N.1

PUBLICATION: JUNE 2014

ANALYSIS OF GLOBAL BIOCHIPS INDUSTRY, 2012-2018 GLOBAL TRENDS, ESTIMATES AND FORECASTS

BIOCHIPS - SEGMENTATION BY SEGMENT Microarrays o By Type  DNA Biochips  Lab-on-Chips  Protein Biochips  Tissue Microarray  Others Cell-on Chips Organ-on-Chips Human-on-Chips o By Technology  Gene Expression  SNP Identification  High Throughput Screening  Proteomics

BY APPLICATION Drug Discovery and Development Diagnostics and Treatment Research Forensic Other (Agriculture, Environmental Sensors, Food Inspection)

Biochip Related Products o Instruments o Reagents and Consumables o Software Services

REPORT FOCUS

“Learn High Potential Market Dynamics for Strategic Business Planning”

The ‘Analysis of Global Biochips Industry, 2012-2018’ reviews the latest trends in biochips sector with a perceptive to disclose the near-future growth prospects in. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.

For more information on this report publication, please reach us at: sales@axisresearchmind.com

2

ANALYSIS OF GLOBAL BIOCHIPS INDUSTRY, 2012-2018 GLOBAL TRENDS, ESTIMATES AND FORECASTS The report focuses on the current market trends, estimates and forecasts for the period 2012-2018. More than 640 in biochips market and 56 leading market players that project improved market activities in the near future are profiled. The report consists of 182 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the industry. The analysis is based on desk research and interviews with biochips researchers and law/ethics specialists, as well as on data collected through the survey, and discussions with experts.

KEY COMPANIES PROFILED BD Biosciences, Promega Corporation, Roche Nimblegen, INC., Perkinelmer Life Sciences, Affymetrix, INC., Agilent Technologies, Life Technologies Corporation, Qiagen N.V., Fluidigm Corporation, GE Healthcare, Amgen, Siemens Medical Solutions, Affibody AB, Hipep Laboratories, Ocimum Biosolutions Ltd., Bioneer Corp. DR. Chip Biotechnology Inc. & many more….

Analysis of Global Biochips Industry, 2012-2018 Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a “Getting the Most from Our Research Analysis” CAGR of 20% globally. Microarrays segment accounts for nearly 70% of the industry value while services indicate lesser than 15% of the market value. North America is expected to maintain the highest market share for the biochips industry by 2018; Asian economies are expected to post a large CAGR of 19 percent during 2012-2018. Higher growth rate favors improved industry investments in Asia-Pacific region in comparison with North America and Europe, going ahead.

For more information on this report publication, please reach us at: sales@axisresearchmind.com

3

ANALYSIS OF GLOBAL BIOCHIPS INDUSTRY, 2012-2018 GLOBAL TRENDS, ESTIMATES AND FORECASTS

GEOGRAPHIC COVERAGE Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. The region-wise distribution of the market consists of North America, Asia-Pacific, Europe and Rest of World with 13 countries, analyzed individually as follows: NORTH AMERICA

USA & CANADA

ASIA-PACIFIC

JAPAN, CHINA, INDIA, SOUTH KOREA, AUSTRALIA & REST OF ASIA-PACIFIC

EUROPE

GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA & REST OF EUROPE

REST OF THE WORLD

GLOBAL BIOCHIP MARKET SHARE - BY MICROARRAYS & APPLICATION - 2015-%

MICROARRAYS

APPLICATION

For more information on this report publication, please reach us at: sales@axisresearchmind.com

4

Turn static files into dynamic content formats.

Create a flipbook